Comparison of the Risk of Severe Complications of Urinary Tract Infections (UTI) Between Patients With Type 2 Diabetes Exposed to Dapagliflozin and Those Exposed to Other Antidiabetic Treatments

15/01/2016
02/07/2024
EU PAS number:
EUPAS12113
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s)

Data sources (types)

Administrative healthcare records (e.g., claims)
Drug dispensing/prescription data
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No